{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:09:04Z","timestamp":1772755744122,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2010,3,21]],"date-time":"2010-03-21T00:00:00Z","timestamp":1269129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Acquired immune deficiency appears to be associated with serious non\u2010AIDS (SNA)\u2010defining conditions such as cardiovascular disease, liver and renal insufficiency and non\u2010AIDS\u2010related malignancies. We analysed the incidence of, and factors associated with, several SNA events in the LATINA retrospective cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Cases of SNA events were recorded among cohort patients. Three controls were selected for each case from cohort members at risk. Conditional logistic models were fitted to estimate the effect of traditional risk factors as well as HIV\u2010associated factors on non\u2010AIDS\u2010defining conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 6007 patients in follow\u2010up, 130 had an SNA event (0.86 events\/100 person\u2010years of follow\u2010up) and were defined as cases (40 with cardiovascular events, 54 with serious liver failure, 35 with non\u2010AIDS\u2010defining malignancies and two with renal insufficiency). Risk factors such as diabetes, hepatitis B and C virus coinfections and alcohol abuse showed an association with events, as expected. The last recorded CD4 T\u2010cell count prior to index date (<jats:italic>P<\/jats:italic>=0.0056, with an average difference of more than 100\u2003cells\/\u03bcL) and area under the CD4 cell curve in the year previous to index date (<jats:italic>P<\/jats:italic>=0.0081) were significantly lower in cases than in controls. CD4 cell count at index date was significantly associated with the outcome after adjusting for risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The incidence and type of SNA events found in this Latin American cohort are similar to those reported in other regions. We found a significant association between immune deficiency and the risk of SNA events, even in patients under antiretroviral treatment.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2010.00824.x","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T04:01:53Z","timestamp":1269230513000},"page":"554-564","source":"Crossref","is-referenced-by-count":37,"title":["Analysis of serious non\u2010AIDS events among HIV\u2010infected adults at Latin American sites"],"prefix":"10.1111","volume":"11","author":[{"given":"WH","family":"Belloso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LC","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JS","family":"Madero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VG","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Ismerio Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Crabtree\u2010Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Garcia Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MB","family":"Lasala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Peinado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MH","family":"Losso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,3]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"22","article-title":"Decline in the AIDS and death rates in the EuroSIDA study","volume":"362","author":"Mocroft A","year":"2003","journal-title":"an observational study"},{"key":"e_1_2_6_3_2","first-page":"36","article-title":"The impact of antiretroviral therapy on AIDS and survival","volume":"2","author":"Lundgren JD","year":"2006","journal-title":"J HIV Ther"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-7-200404060-00024"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200401020-00006"},{"key":"e_1_2_6_6_2","first-page":"119","article-title":"Prognosis of HIV\u20101 infected patients starting highly active antiretroviral therapy","volume":"360","author":"Egger M","year":"2002","journal-title":"a collaborative analysis of prospective studies"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000247229.68246.c5"},{"key":"e_1_2_6_8_2","first-page":"1632","article-title":"Liver\u2010related deaths in persons infected with the human immunodeficiency virus","volume":"166","author":"Weber R","year":"2006","journal-title":"the D:A:D study"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000216375.99560.a2"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000233310.90484.16"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f7cb76"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.15.1632"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283112b77"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062360"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/586713"},{"key":"e_1_2_6_16_2","first-page":"194","article-title":"Comparisons of causes of death and mortality rates among HIV\u2010infected persons","volume":"41","author":"Crum NF","year":"2006","journal-title":"analysis of the pre-, early and late HAART (highly active antiretroviral therapy) eras"},{"key":"e_1_2_6_17_2","first-page":"1663","article-title":"Changes in the cause of death among HIV positive subjects across Europe","volume":"16","author":"Mocroft A","year":"2002","journal-title":"results from the EuroSIDA study"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817bebb3"},{"issue":"1","key":"e_1_2_6_19_2","first-page":"S67","article-title":"Optimizing resource allocation for HIV\/AIDS prevention programmes","volume":"22","author":"Bautista\u2010Arredondo S","year":"2008","journal-title":"an analytical framework"},{"key":"e_1_2_6_20_2","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS).Treatment and care: unprecedented progress remaining challenges. Report on the global AIDS epidemic 2008:129\u2013159."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200212003-00008"},{"key":"e_1_2_6_22_2","first-page":"729","article-title":"AIDS in Latin America","volume":"37","author":"Bastos FI","year":"2008","journal-title":"assessing the current status of the epidemic and the ongoing response"},{"key":"e_1_2_6_23_2","volume-title":"Modern Epidemiology","author":"Rothman KJ","year":"2008"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.2307\/2531050"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn217"},{"key":"e_1_2_6_26_2","first-page":"224","article-title":"Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study)","volume":"372","author":"McQueen MJ","year":"2008","journal-title":"a case\u2013control study"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050203"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-006-0730-0"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1310\/HT0W-NX2N-U2BM-7LUU"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.104.3.257"},{"key":"e_1_2_6_31_2","first-page":"1417","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV\u2010infected patients enrolled in the D:A:D study","volume":"371","author":"D:A:D Study Group .","year":"2008","journal-title":"a multi-cohort collaboration"},{"key":"e_1_2_6_32_2","first-page":"1979","article-title":"Natural history of hepatitis C virus infection in HIV\u2010infected individuals and the impact of HIV in the era of highly active antiretroviral therapy","volume":"22","author":"Thein HH","year":"2008","journal-title":"a meta-analysis"},{"key":"e_1_2_6_33_2","first-page":"621","article-title":"The implications of antiviral drugs with activity against hepatitis B virus and HIV","volume":"20","author":"Bottecchia M","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.11.015"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062744"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/592115"},{"key":"e_1_2_6_37_2","unstructured":"Crabtree\u2010RamirezB G\u00f3mez PalacioM Rodr\u00edguez RiveraV Reyes\u2010Ter\u00e1nG.Baseline characteristics of HIV\u2010infected patients attending a National Institute of Health in Mexico City: evidence of late detection of HIV infection and the urgent need for efficient. Voluntary Counseling and Testing (VCT) programs.XVII International AIDS Conference. Mexico DF Mexico August 2008. [Abstract THPE0244]."}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2010.00824.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2010.00824.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T21:02:53Z","timestamp":1698699773000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2010.00824.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,3]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1468-1293.2010.00824.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2010.00824.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,3]]}}}